NIMZOLID-600

Description

Linezolid 600mg Tablets belong to the oxazolidinone class of antibiotics, primarily used to treat serious bacterial infections resistant to other antibiotics. This formulation is effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).

Composition & Mechanism of Action:

• Linezolid 600mg: Inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit, halting bacterial growth and multiplication.

Key Benefits:

✔ Effective against drug-resistant bacterial infections
✔ Suitable for treating severe infections like pneumonia, skin, and soft tissue infections
✔ High bioavailability, ensuring quick therapeutic action
✔ WHO-GMP certified for assured quality

Indications:

• Community-acquired pneumonia (CAP)
• Hospital-acquired pneumonia (HAP)
• Skin and soft tissue infections
• Infections caused by MRSA and VRE
• Bone and joint infections
• Bacteremia caused by Gram-positive bacteria

Dosage & Administration:

• Adult Dose: 600mg every 12 hours for 10 to 14 days or as directed by a healthcare professional
• Should be taken with or without food
• Complete the entire course of treatment to prevent antibiotic resistance

Side Effects:

• Headache or dizziness
• Nausea or vomiting
• Diarrhea or constipation
• Changes in taste sensation
• Decreased blood cell counts (long-term use) — regular monitoring required